Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/12/2025

Management of Type 2 Non-ST-Elevation Myocardial Infarction (NSTEMI)

Initial Assessment and Management

  • The American College of Cardiology recommends identifying and treating the underlying cause of supply-demand mismatch, such as hypoxemia, tachycardia, hypotension, anemia, or sepsis, rather than pursuing emergent coronary angiography in patients with Type 2 NSTEMI 1, 2
  • Obtain a 12-lead ECG within 10 minutes to confirm the absence of ST-elevation and rule out STEMI requiring immediate reperfusion, as recommended by the American Heart Association 3, 4
  • Place the patient on continuous cardiac monitoring with defibrillation capability to detect life-threatening arrhythmias, as suggested by the American College of Cardiology 1, 2
  • Administer supplemental oxygen if arterial oxygen saturation is less than 90%, or if the patient has respiratory distress or other high-risk features of hypoxemia, as recommended by the American Thoracic Society 3
  • Assess vital signs immediately, including blood pressure, heart rate, oxygen saturation, and Killip classification, to identify hemodynamic instability, as recommended by the American College of Cardiology 4

Medical Therapy

  • The American College of Cardiology suggests that aspirin 150-300 mg loading dose may be considered if there is concern for mixed Type 1/Type 2 pathology or underlying coronary disease, but it is not mandatory for pure Type 2 MI 4
  • Avoid dual antiplatelet therapy, such as aspirin plus P2Y12 inhibitor, unless there is evidence of acute coronary thrombosis or high-risk features suggesting a Type 1 component, as recommended by the American College of Cardiology 4
  • Avoid routine anticoagulation, such as heparin, enoxaparin, or fondaparinux, unless there is evidence of acute thrombosis, as suggested by the American College of Chest Physicians 4
  • High-intensity statin therapy should be initiated if the patient has underlying coronary disease, as recommended by the American College of Cardiology 4

Risk Stratification

  • The American Heart Association recommends proceeding to immediate angiography only if the patient has hemodynamic instability, cardiogenic shock, recurrent or ongoing chest pain refractory to medical therapy, life-threatening arrhythmias, or cardiac arrest, or if there are mechanical complications of MI 4, 6
  • Consider early angiography within 24 hours if there are dynamic ST- or T-wave changes suggesting active ischemia, a GRACE score greater than 140, or concern for mixed Type 1/Type 2 pathology, as recommended by the American College of Cardiology 3, 4, 5

Diagnostic Evaluation

  • Urgent transthoracic echocardiography should be performed to assess left ventricular function and identify mechanical complications if the patient is hemodynamically unstable, as recommended by the American Society of Echocardiography 6
  • Serial troponin measurements should be taken at 3-6 hour intervals to assess for ongoing injury, as suggested by the American College of Cardiology 3, 5
  • Continuous multi-lead ST-segment monitoring should be used if available, as recommended by the American Heart Association 5

REFERENCES

4

Approach to Acute Coronary Syndrome (ACS) [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

5

Management of Hemodynamically Unstable NSTEMI with Severe Hypoxemia [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

6

Immediate Management for Stat Cardiac Panel [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025